172 related articles for article (PubMed ID: 32884448)
1. NONO promotes hepatocellular carcinoma progression by enhancing fatty acids biosynthesis through interacting with ACLY mRNA.
Ding H; Liu J; Wang C; Su Y
Cancer Cell Int; 2020; 20():425. PubMed ID: 32884448
[TBL] [Abstract][Full Text] [Related]
2. Splicing Regulator p54
Hu Z; Dong L; Li S; Li Z; Qiao Y; Li Y; Ding J; Chen Z; Wu Y; Wang Z; Huang S; Gao Q; Zhao Y; He X
Hepatology; 2020 Aug; 72(2):548-568. PubMed ID: 31815296
[TBL] [Abstract][Full Text] [Related]
3. Paraspeckle Promotes Hepatocellular Carcinoma Immune Escape by Sequestering IFNGR1 mRNA.
Zan J; Zhao X; Deng X; Ding H; Wang B; Lu M; Wei Z; Huang Z; Wang S
Cell Mol Gastroenterol Hepatol; 2021; 12(2):465-487. PubMed ID: 33667716
[TBL] [Abstract][Full Text] [Related]
4. ATP-citrate lyase regulates stemness and metastasis in hepatocellular carcinoma via the Wnt/β-catenin signaling pathway.
Han Q; Chen CA; Yang W; Liang D; Lv HW; Lv GS; Zong QN; Wang HY
Hepatobiliary Pancreat Dis Int; 2021 Jun; 20(3):251-261. PubMed ID: 33129711
[TBL] [Abstract][Full Text] [Related]
5. Arginine methylation and citrullination of splicing factor proline- and glutamine-rich (SFPQ/PSF) regulates its association with mRNA.
Snijders AP; Hautbergue GM; Bloom A; Williamson JC; Minshull TC; Phillips HL; Mihaylov SR; Gjerde DT; Hornby DP; Wilson SA; Hurd PJ; Dickman MJ
RNA; 2015 Mar; 21(3):347-59. PubMed ID: 25605962
[TBL] [Abstract][Full Text] [Related]
6. ST8SIA6-AS1 promotes the development of hepatocellular carcinoma cells through miR-338-3p/NONO Axis.
Kuai J; Zheng L; Yi X; Liu Z; Qiu B; Lu Z; Jiang Y
Dig Liver Dis; 2021 Sep; 53(9):1192-1200. PubMed ID: 33722502
[TBL] [Abstract][Full Text] [Related]
7. ATP citrate lyase inhibitor triggers endoplasmic reticulum stress to induce hepatocellular carcinoma cell apoptosis via p-eIF2α/ATF4/CHOP axis.
Zheng Y; Zhou Q; Zhao C; Li J; Yu Z; Zhu Q
J Cell Mol Med; 2021 Feb; 25(3):1468-1479. PubMed ID: 33393219
[TBL] [Abstract][Full Text] [Related]
8. [Expression and Clinical Significance of ATP Citrate Lyase in Hepatocellular Carcinoma].
Yu HJ; Wei LY; Liu SS; Zhang ZT; Guan CJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Oct; 45(5):743-751. PubMed ID: 37927015
[TBL] [Abstract][Full Text] [Related]
9. Targeting the splicing factor NONO inhibits GBM progression through GPX1 intron retention.
Wang X; Han M; Wang S; Sun Y; Zhao W; Xue Z; Liang X; Huang B; Li G; Chen A; Li X; Wang J
Theranostics; 2022; 12(12):5451-5469. PubMed ID: 35910786
[No Abstract] [Full Text] [Related]
10. GNAS promotes inflammation-related hepatocellular carcinoma progression by promoting STAT3 activation.
Ding H; Zhang X; Su Y; Jia C; Dai C
Cell Mol Biol Lett; 2020; 25():8. PubMed ID: 32123532
[TBL] [Abstract][Full Text] [Related]
11. Established and Evolving Roles of the Multifunctional Non-POU Domain-Containing Octamer-Binding Protein (NonO) and Splicing Factor Proline- and Glutamine-Rich (SFPQ).
Yu D; Huang CJ; Tucker HO
J Dev Biol; 2024 Jan; 12(1):. PubMed ID: 38248868
[TBL] [Abstract][Full Text] [Related]
12. Nuclear scaffold protein p54
Shen M; Zhang R; Jia W; Zhu Z; Zhao X; Zhao L; Huang G; Liu J
Oncogene; 2021 Jun; 40(24):4167-4183. PubMed ID: 34079086
[TBL] [Abstract][Full Text] [Related]
13. NONO promotes gallbladder cancer cell proliferation by enhancing oncogenic RNA splicing of DLG1 through interaction with IGF2BP3/RBM14.
Yang ZY; Zhao C; Liu SL; Pan LJ; Zhu YD; Zhao JW; Wang HK; Ye YY; Qiang J; Shi LQ; Mei JW; Xie Y; Gong W; Shu YJ; Dong P; Xiang SS
Cancer Lett; 2024 Apr; 587():216703. PubMed ID: 38341127
[TBL] [Abstract][Full Text] [Related]
14. NEAT1 paraspeckle promotes human hepatocellular carcinoma progression by strengthening IL-6/STAT3 signaling.
Wang S; Zhang Q; Wang Q; Shen Q; Chen X; Li Z; Zhou Y; Hou J; Xu B; Li N; Cao X
Oncoimmunology; 2018; 7(11):e1503913. PubMed ID: 30377567
[TBL] [Abstract][Full Text] [Related]
15. The transcription-splicing protein NonO/p54nrb and three NonO-interacting proteins bind to distal enhancer region and augment rhodopsin expression.
Yadav SP; Hao H; Yang HJ; Kautzmann MA; Brooks M; Nellissery J; Klocke B; Seifert M; Swaroop A
Hum Mol Genet; 2014 Apr; 23(8):2132-44. PubMed ID: 24301678
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular Carcinoma and Nuclear Paraspeckles: Induction in Chemoresistance and Prediction for Poor Survival.
Kessler SM; Hosseini K; Hussein UK; Kim KM; List M; Schultheiß CS; Schulz MH; Laggai S; Jang KY; Kiemer AK
Cell Physiol Biochem; 2019; 52(4):787-801. PubMed ID: 30946555
[TBL] [Abstract][Full Text] [Related]
17. PSPC1, NONO, and SFPQ are expressed in mouse Sertoli cells and may function as coregulators of androgen receptor-mediated transcription.
Kuwahara S; Ikei A; Taguchi Y; Tabuchi Y; Fujimoto N; Obinata M; Uesugi S; Kurihara Y
Biol Reprod; 2006 Sep; 75(3):352-9. PubMed ID: 16641145
[TBL] [Abstract][Full Text] [Related]
18. Identification and integrative analysis of ACLY and related gene panels associated with immune microenvironment reveal prognostic significance in hepatocellular carcinoma.
Xu Y; Zhang Z; Xu D; Yang X; Zhou L; Zhu Y
Cancer Cell Int; 2021 Aug; 21(1):409. PubMed ID: 34344378
[TBL] [Abstract][Full Text] [Related]
19. Pro-oncogenic Roles of HLXB9 Protein in Insulinoma Cells through Interaction with Nono Protein and Down-regulation of the c-Met Inhibitor Cblb (Casitas B-lineage Lymphoma b).
Desai SS; Kharade SS; Parekh VI; Iyer S; Agarwal SK
J Biol Chem; 2015 Oct; 290(42):25595-608. PubMed ID: 26342078
[TBL] [Abstract][Full Text] [Related]
20. Loss of NPPA-AS1 promotes heart regeneration by stabilizing SFPQ-NONO heteromer-induced DNA repair.
Fu W; Ren H; Shou J; Liao Q; Li L; Shi Y; Jose PA; Zeng C; Wang WE
Basic Res Cardiol; 2022 Mar; 117(1):10. PubMed ID: 35247074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
